galactosyl-(1-3)galactose has been researched along with epidermal growth factor in 1 studies
| Studies (galactosyl-(1-3)galactose) | Trials (galactosyl-(1-3)galactose) | Recent Studies (post-2010) (galactosyl-(1-3)galactose) | Studies (epidermal growth factor) | Trials (epidermal growth factor) | Recent Studies (post-2010) (epidermal growth factor) |
|---|---|---|---|---|---|
| 493 | 3 | 100 | 24,155 | 217 | 4,699 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kang, HJ; Kim, JM; Kim, JS; Kim, SJ; Lee, H; Park, CG; Park, EM; Shin, JS | 1 |
1 other study(ies) available for galactosyl-(1-3)galactose and epidermal growth factor
| Article | Year |
|---|---|
Increase in anti-Gal IgM level is associated with early graft failure in intraportal porcine islet xenotransplantation.
Topics: Animals; Antibodies; Area Under Curve; CD40 Antigens; CD40 Ligand; Disaccharides; Epidermal Growth Factor; Graft Rejection; Immunoglobulin G; Immunoglobulin M; Immunosuppressive Agents; Islets of Langerhans Transplantation; Macaca mulatta; ROC Curve; Swine; Transplantation, Heterologous | 2015 |